| Code | 8926D | ||||||||||
| MA number | 87/0277/21-S | ||||||||||
| Product Form: | sol iru 1x3ml/30 mg (striek.inj.skl.napl.+ihla) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 87 - VARIA I | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.10.2021 |
| Validity: | 29.10.2026 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Icatibant Glenmark 30 mg sol iru_10_2021.pdf
|
| SPC: |
SPC_Icatibant Glenmark 30 mg sol iru_10_2021.pdf
|
| Safety feature | Yes |
| Data update: | 05.11.2021 |
